• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV

CLINUVEL PHARMACEUTICALS LIMITED - Corporate Spotlight

1.09% ! $12.97
Market Cap $650.1M  !

Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on... Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.More

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$12.97
Change
0.140(1.09%)
Mkt cap ! $650.1M
Open High Low Value Volume
$12.90 $13.25 $12.88 $1.268M 97.28K

Buyers (Bids)

No. Vol. Price($)
1 1000 $12.93
 

Sellers (Offers)

Price($) Vol. No.
$12.97 365 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
Last
$12.97
  Change
0.140 ( 1.08 %)
Open High Low Volume
$13.15 $13.24 $12.90 10099
Last updated 15.59pm 31/07/2025 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.